Skip to content

Clinical trials

Terminated Urologic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Status: Terminated Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20153
20171
20203
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celldex Therapeutics2
Rainier Therapeutics2
Spinal Singularity2
Avation Medical, Inc.1
Bioniche Life Sciences Inc.1
Endo USA Inc., a Keenova Therapeutics Company1
Goldfinch Bio, Inc.1
Johns Hopkins University1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
NiKang Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases13
Neoplasms5
Urinary Bladder Diseases5
Urinary Bladder Neoplasms5
Urogenital Neoplasms5
Urologic Neoplasms5
Carcinoma, Transitional Cell4
Kidney Diseases4
Carcinoma, Renal Cell3
Kidney Neoplasms3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.